F770 in Connecticut. Pick another state for the same tag.
Against expectation — 2025
Connecticut cites F770 less often than its own record predicts
Versus expected share0.60×
0.60 times the national share — cited less often here than elsewhere.
Share of Connecticut citations0.12%
Of every deficiency written in Connecticut in 2025, this is the portion that was F770.
Connecticut0.12%
National0.21%
Share of all citations that were F770.
Each state is measured against its own expected share, not against other states.
In the surveyor’s words
What Connecticut surveyors wrote
F770 findings written in Connecticut, one from each severity band recorded here, most serious first.
Severity is as the surveyor wrote it. Some findings had already been corrected before the survey.
D · No harm, potential for more than minimal, isolatedOctober 2, 2025
Based on clinical record reviews, facility documentation, facility policy and interviews for two (2) of twenty-one (21) randomly selected residents (Residents #5 and #11), the facility failed to ensure blood work was obtained per the physician's order. The findings include:1. Resident #5's diagnoses included pneumonia, acute and chronic respiratory failure with hypoxia (low levels of oxygen in body tissues), Congestive Heart Failure (CHF), anemia (low levels of healthy red blood cells to carry oxygen throughout the body), generalized edema (severe buildup of fluid in the tissues of several parts of the body) and hypocalcemia (low calcium levels in the blood). …
B · No harm, potential for minimal, patternDecember 12, 2017
Based on observation, review of facility policy and staff interview for 2 of 4 medication carts, the facility failed to ensure biologicals were maintained within their expiration. The findings include:
Observation of the East/West Odd medication cart on [DATE] 9:30 AM with RN #1 identified 1 opened bottle of Hemoccult developer, 15ml, stored in the medication cart, and expired ,[DATE].
Observation in the Northwest Even medication cart on [DATE] at 11:30 AM with RN #3 identified 1 bottle of Hemoccult developer 15ml, stored in medication cart and expired ,[DATE],
Interview with the Infection Control Nurse, RN #6, on [DATE] at 1:50PM identified that hemoccult developer should not be stored in the medication cart because of the potential for cross contamination. …
Deficiency Index is independent and is not affiliated with, endorsed by, or approved by CMS, Medicare, or any government agency. About this data · Report a correction